NEW DIRECTIONS IN PHARMACOGENETICS AND ECOGENETICS

这次国际会议涉及三个新的药物遗传和生态遗传重要性领域：1)食品和饮食成分；2)对感染的遗传防御；3)对药物和环境毒物的反应。后一主题分为两个部分，分别阐述了遗传药物变异的遗传和功能分析的新方向，以及与诊断药物遗传测试相关的考虑因素：优化药物发现和药物治疗。会议的目标是：a)探索和记录药物遗传学和生态遗传学的最新进展，这些进展将改善人类群体的健康保健；b)促进从事新技术设计和实施的基础和临床科学家之间的互动，这些新技术能够在参与新药临床试验的受试者和医院患者中筛选具有药物遗传学和生态遗传学重要性的特征。演讲者在其主题的前沿具有国内和国际水准。一些人在药物遗传学和生态遗传学方面建立了声誉，但我们也寻求了包括其他领域的研究人员在内的平衡。发言者名单上包括一些较年轻的研究人员，他们为潜在的遗传药学和生态遗传兴趣的研究取得了显着进展，并在发现新药和改善病人护理方面利用了新知识。

This international conference addresses three new areas of pharmacogenetic and ecogenetic importance: 1) Foods and dietary constituents; 2) Genetic defenses against infections; and 3) Responses to drugs and environmental toxicants. The latter topic is subdivided in two parts which address New directions in the genetic and functional analysis of pharmacogenetic variants, and Considerations relevant to diagnostic pharmacogenetic testing: Optimizing drug discovery and drug therapy. The conference objective is a) to explore and document recent advances in pharmacogenetics and ecogenetics that will yield improved health care for large segments of human populations, and b) to facilitate the interaction of basic and clinical scientists engaged in the design and implementation of new technologies capable of screening for traits of pharmacogenetic and ecogenetic importance among subjects involved in clinical trials of new drugs and hospital patients. The speakers are of national and international caliber at the cutting edge of their topic. Some have established reputations in pharmacogenetics and ecogenetics, but we have also sought a balance that includes investigators from other fields. The roster of speakers includes a number of younger investigators who are contributing to the remarkable advances in research of potential pharmacogenetic and ecogenetic interest and to the utilization of the new knowledge in the discovery of new drugs and improved patient care.